AMAG PHARMACEUTICALS, INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMAG PHARMACEUTICALS, INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President and CEO | Option Exercise | A | 21.13 | 93,800 | 1,981,994 | 93,800 | |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President and CEO | Grant | A | 0.00 | 15,600 | 0 | 169,338 | 153.7 K to 169.3 K (+10.15 %) |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | VP, Chief Accountin ... | Option Exercise | A | 21.13 | 18,800 | 397,244 | 18,800 | |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | VP, Chief Accountin ... | Grant | A | 0.00 | 3,100 | 0 | 14,696 | 11.6 K to 14.7 K (+26.73 %) |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | Townsend Scott B | SVP, General Counse ... | Option Exercise | A | 21.13 | 30,000 | 633,900 | 30,000 | |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | Townsend Scott B | SVP, General Counse ... | Grant | A | 0.00 | 5,000 | 0 | 34,471 | 29.5 K to 34.5 K (+16.97 %) |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | Caffe Steven | SVP, Ch. Dev. and R ... | Option Exercise | A | 21.13 | 26,300 | 555,719 | 26,300 | |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | Caffe Steven | SVP, Ch. Dev. and R ... | Grant | A | 0.00 | 4,400 | 0 | 39,400 | 35 K to 39.4 K (+12.57 %) |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Option Exercise | A | 21.13 | 33,800 | 714,194 | 33,800 | |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Grant | A | 0.00 | 5,600 | 0 | 88,134 | 82.5 K to 88.1 K (+6.79 %) |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | A | 21.13 | 26,300 | 555,719 | 26,300 | |
| Feb 28 2014 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Grant | A | 0.00 | 4,400 | 0 | 28,400 | 24 K to 28.4 K (+18.33 %) |
| Feb 26 2014 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 21.58 | 400 | 8,632 | 24,000 | 24.4 K to 24 K (-1.64 %) |
| Feb 26 2014 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 21.71 | 434 | 9,422 | 24,400 | 24.8 K to 24.4 K (-1.75 %) |
| Feb 25 2014 | AVM | AMAG PHARMACEUTICA ... | Edward P. Jordan | SVP, Sales and Mark ... | Option Exercise | A | 21.76 | 30,000 | 652,800 | 30,000 | |
| Feb 25 2014 | AVM | AMAG PHARMACEUTICA ... | Edward P. Jordan | SVP, Sales and Mark ... | Grant | A | 0.00 | 15,000 | 0 | 15,500 | 500 to 15.5 K (+3,000.00 %) |